165 related articles for article (PubMed ID: 26810066)
1. Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.
Wang H; Jiang D; Song Q; Xu C; Shi Y; Li X; Huang J; Xu Y; Sujie A; Zeng H; Zhong Y; Tan L; Hou Y
Tumour Biol; 2016 Jul; 37(7):9771-9. PubMed ID: 26810066
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
3. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
[TBL] [Abstract][Full Text] [Related]
4. Effect of c-Met and CD44v6 Expression in Resistance to Chemotherapy in Esophageal Squamous Cell Carcinoma.
Hara T; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2019 Mar; 26(3):899-906. PubMed ID: 30610559
[TBL] [Abstract][Full Text] [Related]
5. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
He Z; Yi J; Jin L; Pan B; Chen L; Song H
Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor-related tumor markers and clinical outcomes with erlotinib in non-small cell lung cancer: an analysis of patients from german centers in the TRUST study.
Schneider CP; Heigener D; Schott-von-Römer K; Gütz S; Laack E; Digel W; Guschall WR; Franke A; Bodenstein H; Schmidtgen C; Reck M
J Thorac Oncol; 2008 Dec; 3(12):1446-53. PubMed ID: 19057271
[TBL] [Abstract][Full Text] [Related]
8. Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.
Yang YL; Xu KL; Zhou Y; Gao X; Chen LR
Chin Med J (Engl); 2012 Feb; 125(3):450-4. PubMed ID: 22490401
[TBL] [Abstract][Full Text] [Related]
9. Clinical effect of E-series of prostaglandin receptor 2 and epidermal growth factor receptor signal pathways in the development of esophageal squamous cell carcinoma.
Xu KK; Tian F; Chang D; Gong M; Fan JQ; Wang TY
Dis Esophagus; 2014; 27(4):388-95. PubMed ID: 24883443
[TBL] [Abstract][Full Text] [Related]
10. Icotinib in Patients with Pretreated Advanced Esophageal Squamous Cell Carcinoma with EGFR Overexpression or EGFR Gene Amplification: A Single-Arm, Multicenter Phase 2 Study.
Huang J; Fan Q; Lu P; Ying J; Ma C; Liu W; Liu Y; Tan F; Sun Y
J Thorac Oncol; 2016 Jun; 11(6):910-7. PubMed ID: 26980473
[TBL] [Abstract][Full Text] [Related]
11. Expression and clinical significance of c-Met in advanced esophageal squamous cell carcinoma.
Xu Y; Peng Z; Li Z; Lu M; Gao J; Li Y; Li Y; Shen L
BMC Cancer; 2015 Jan; 15():6. PubMed ID: 25588551
[TBL] [Abstract][Full Text] [Related]
12. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.
Yoo SB; Kim YJ; Kim H; Jin Y; Sun PL; Jheon S; Lee JS; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S545-52. PubMed ID: 23579873
[TBL] [Abstract][Full Text] [Related]
14. Expression of epidermal growth factor receptor is an independent prognostic factor for esophageal squamous cell carcinoma.
Wang Q; Zhu H; Xiao Z; Zhang W; Liu X; Zhang X; He J; Sun K; Wang L; Xu N
World J Surg Oncol; 2013 Oct; 11():278. PubMed ID: 24131756
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
16. Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
Tran TN; Selinger CI; Kohonen-Corish MR; McCaughan B; Kennedy C; O'Toole SA; Cooper WA
Clin Lung Cancer; 2016 Jan; 17(1):30-8.e1. PubMed ID: 26395411
[TBL] [Abstract][Full Text] [Related]
17. c-Met in esophageal squamous cell carcinoma: an independent prognostic factor and potential therapeutic target.
Ozawa Y; Nakamura Y; Fujishima F; Felizola SJ; Takeda K; Okamoto H; Ito K; Ishida H; Konno T; Kamei T; Miyata G; Ohuchi N; Sasano H
BMC Cancer; 2015 Jun; 15():451. PubMed ID: 26036285
[TBL] [Abstract][Full Text] [Related]
18. Large-scale comprehensive immunohistochemical biomarker analyses in esophageal squamous cell carcinoma.
Hatogai K; Fujii S; Kojima T; Daiko H; Nomura S; Doi T; Kitano S; Ohtsu A; Takiguchi Y; Yoshino T; Ochiai A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2351-2361. PubMed ID: 28756492
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma.
Jiang D; Li X; Wang H; Shi Y; Xu C; Lu S; Huang J; Xu Y; Zeng H; Su J; Hou Y; Tan L
BMC Cancer; 2015 May; 15():377. PubMed ID: 25953424
[TBL] [Abstract][Full Text] [Related]
20. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
